Andrew Brackmann
Stock Analyst at William Blair
(4.84)
# 390
Out of 4,520 analysts
155
Total ratings
69.6%
Success rate
34.9%
Average return
Main Sectors:
Stocks Rated by Andrew Brackmann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Rated: Hold | n/a | $158.17 | - | 4 | Jul 2, 2026 | |
| QDEL QuidelOrtho | Rated: Hold | n/a | $17.38 | - | 12 | Jul 2, 2026 | |
| XGN Exagen | Rated: Hold | n/a | $4.39 | - | 8 | Jul 2, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | n/a | $6.62 | - | 10 | Jun 18, 2026 | |
| ADPT Adaptive Biotechnologies | Reiterated: Buy | n/a | $22.92 | - | 12 | Jun 16, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | n/a | $210.68 | - | 6 | Jun 15, 2026 | |
| TEM Tempus AI | Reiterated: Hold | n/a | $52.47 | - | 11 | Jun 1, 2026 | |
| NEO NeoGenomics | Maintained: Hold | n/a | $14.61 | - | 11 | May 27, 2026 | |
| CDNA CareDx | Reiterated: Hold | n/a | $39.73 | - | 7 | May 27, 2026 | |
| GH Guardant Health | Maintained: Buy | n/a | $155.87 | - | 14 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4228 | - | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $271.39 | - | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.60 | - | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.05 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $130.31 | - | 7 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.13 | - | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $20.19 | - | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $283.36 | - | 5 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $41.15 | -7.65% | 7 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $100.68 | - | 2 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.69 | n/a | 1 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $5.03 | n/a | 1 | Feb 3, 2022 |
Becton, Dickinson and Company
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $158.17
Upside: -
QuidelOrtho
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $17.38
Upside: -
Exagen
Jul 2, 2026
Rated: Hold
Price Target: n/a
Current: $4.39
Upside: -
Butterfly Network
Jun 18, 2026
Maintained: Buy
Price Target: n/a
Current: $6.62
Upside: -
Adaptive Biotechnologies
Jun 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.92
Upside: -
Quest Diagnostics
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $210.68
Upside: -
Tempus AI
Jun 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $52.47
Upside: -
NeoGenomics
May 27, 2026
Maintained: Hold
Price Target: n/a
Current: $14.61
Upside: -
CareDx
May 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $39.73
Upside: -
Guardant Health
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $155.87
Upside: -
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4228
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $271.39
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.60
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.05
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $130.31
Upside: -
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $59.13
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $20.19
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $283.36
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: $38
Current: $41.15
Upside: -7.65%
Jan 23, 2026
Maintained: Buy
Price Target: n/a
Current: $100.68
Upside: -
Oct 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.69
Upside: n/a
Feb 3, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $5.03
Upside: n/a